Vanta Bioscience Limited announced at the SBM held on November 11, 2021, the board had transacted the resignation of Mr. Kiran Kumar Annabatula as Chief Financial Officer effective November 11, 2021 and appointment of Mr. Dokka Venkata Sathya Murali as Chief Financial Officer effective November 11, 2021. Mr. Dokka Venkata Sathya Murali has over 30 Years of Experience in Corporate Finance, Accounts, Statutory Compliance, Tax Planning, Budgeting etc.